Related Experiment Video
Updated: Sep 28, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
Published on: November 4, 2011
Superparamagnetic iron oxide (Feridex)-enhanced MRI in diagnosis of focal hepatic lesions
Ge Wen1, Xue-Lin Zhang, Ren-Min Chang
1Medical Imaging Center, Nanfang Hospital, First Military Medical University, Guangzhou 510515, China.
Objective:
To evaluate the diagnostic value of superparamagnetic iron oxide (SPIO)-enhanced magnetic resonance imaging (MRI) for hepatic focal solid lesions.
Methods:
SPIO (Feridex)-enhanced MRI examination was performed in 28 cases of hepatic space-occupying lesions defined by CT or MRI or other methods. In post-contrast enhanced examination, the signal intensity and contrast-to-noise ratio (CNR) were measured in lesions and normal hepatic parenchyma in T2-weighted images (T2WI) and were compared with those in pre-contrast enhanced MRI. The number and morphology of the lesions were visualized for qualitative diagnostic analysis.
Results:
In Feridex-enhanced MRI, the signal intensity of normal hepatic parenchyma was decreased while the CNR between lesions and normal liver tissues significantly improved in comparison with that in pre-contrast enhanced examination.
Conclusion:
Feridex-enhanced T2WI examination significantly improves detection of hepatic lesions and is valuable in diagnosing hepatic focal solid lesions.
Insights
Superparamagnetic iron oxide (SPIO)-enhanced MRI significantly improves the detection of hepatic focal solid lesions. This advanced imaging technique enhances contrast between lesions and normal liver tissue for better diagnosis.
Area of Science:
- Radiology
- Medical Imaging
- Hepatology
Background:
- Hepatic focal solid lesions require accurate diagnostic methods.
- Superparamagnetic iron oxide (SPIO) contrast agents offer unique properties for MRI.
Purpose of the Study:
- To evaluate the diagnostic value of SPIO-enhanced MRI for hepatic focal solid lesions.
- To assess the effectiveness of Feridex-enhanced T2-weighted imaging (T2WI) in lesion detection.
Main Methods:
- SPIO (Feridex)-enhanced MRI was performed on 28 patients with hepatic lesions.
- Signal intensity and contrast-to-noise ratio (CNR) were measured in T2WI pre- and post-contrast.
- Lesion number and morphology were analyzed qualitatively.
Main Results:
- Feridex-enhanced MRI showed decreased signal intensity in normal hepatic parenchyma.
- A significant improvement in CNR between lesions and normal liver tissue was observed post-contrast.
- Enhanced visualization of lesion number and morphology was achieved.
Conclusions:
- Feridex-enhanced T2WI significantly improves the detection of hepatic lesions.
- SPIO-enhanced MRI is a valuable tool for diagnosing hepatic focal solid lesions.
- The technique enhances contrast, aiding in lesion characterization.
Related Concept Videos
Magnetic Resonance Imaging
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Imaging Studies IV: Magnetic Resonance Imaging

